Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,475 across all filing types
Latest filing 2018-03-28 Annual Report
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2017
Annual Report Classification · 100% confidence The document is a detailed financial report containing audited consolidated financial results for the year ended 31 December 2017, including comprehensive income statements, financial position statements, segment information, notes on accounting standards, and detailed financial disclosures. It is clearly a full annual financial report with extensive financial data and analysis, not merely an announcement or summary. The presence of audited consolidated financial statements and notes confirms it is an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2017
2018-03-28 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from the company about the date of a board meeting where the final results for the year ended 31 December 2017 will be approved and a final dividend considered. It does not contain any financial data or the actual report but only announces the upcoming board meeting and the agenda. The document length is only 1679 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about the timing or scheduling of report releases or board meetings are best classified as Regulatory Filings (RNS) since it does not fit other more specific categories and is not the report itself.
2018-03-15 English
Monthly Return of Equity Issuer on movements in Securities for the month ended 28 February 2018
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/2/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document length is over 13,000 characters and contains detailed data, so it is not a brief announcement or report publication notice. The best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit into more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS), since it covers a broad range of share capital movements and is a monthly return filing to the exchange.
2018-03-01 English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 January 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/1/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update or share capital change report. Given the detailed monthly movements in share capital and securities, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief announcement but a substantive report on capital changes.
2018-02-05 English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 December 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in the company's share capital structure during a specific month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting share capital movements, typical for stock exchange compliance. It is not an annual or interim report, earnings release, or management report. It is not a proxy, AGM material, or voting result. It is a regulatory announcement about share capital changes, fitting best under Regulatory Filings (RNS). The document length is substantial and contains detailed data, so it is not a mere announcement of a report (RPA). Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2018-01-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, World Houseware (Holdings) Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share issues pursuant to share option exercises and confirms compliance with Listing Rules regarding share repurchases. The document is regulatory in nature, reporting share capital changes and repurchase activities as required by the Hong Kong Stock Exchange rules. It is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about capital changes and share buybacks. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares and related capital changes.
2017-12-20 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.